Novavax’s COVID-19 vaccine has been shown to be 96% effective against the original strain of coronavirus in a new study in the UK, the company announced on Thursday.
The image of the Maryland company was also 86% effective against the more contagious variant first discovered in the UK and now widespread in the US and New York.
In a smaller study in South Africa, the Novavax vaccine was around 55% effective in preventing the disease when tested against volunteers exposed mainly to the new variant first identified there.
But in both the UK and South African studies, shooting was 100% effective in preventing serious illness and death.
The company will use the results to apply for authorization to use the vaccine in different countries. It was not immediately clear whether he would seek FDA approval based on findings in the UK or whether he would wait for an ongoing test in the US to be completed.
The latest findings are in line with the interim results announced in January, when Novavax javelin was found to be 96% effective against the original coronavirus and approximately 86% effective against the UK variant.
There are currently three vaccines authorized for use in the United States by Pfizer-BioNTech, Moderna and Johnson & Johnson.
With Post threads
